GB2331763B - A Multicellular in vitro assay of angiogenesis - Google Patents

A Multicellular in vitro assay of angiogenesis

Info

Publication number
GB2331763B
GB2331763B GB9821068A GB9821068A GB2331763B GB 2331763 B GB2331763 B GB 2331763B GB 9821068 A GB9821068 A GB 9821068A GB 9821068 A GB9821068 A GB 9821068A GB 2331763 B GB2331763 B GB 2331763B
Authority
GB
United Kingdom
Prior art keywords
multicellular
angiogenesis
vitro assay
vitro
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9821068A
Other versions
GB9821068D0 (en
GB2331763A (en
GB2331763A9 (en
Inventor
Eileen T Grant
Graham T Bell
Stephen Bloor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biocure Ltd
Original Assignee
Biocure Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of GB2331763A9 publication Critical patent/GB2331763A9/en
Priority claimed from GBGB9720987.8A external-priority patent/GB9720987D0/en
Application filed by Biocure Ltd filed Critical Biocure Ltd
Priority to GB9821068A priority Critical patent/GB2331763B/en
Publication of GB9821068D0 publication Critical patent/GB9821068D0/en
Publication of GB2331763A publication Critical patent/GB2331763A/en
Application granted granted Critical
Publication of GB2331763B publication Critical patent/GB2331763B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5064—Endothelial cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5029—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell motility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
GB9821068A 1997-10-01 1998-09-29 A Multicellular in vitro assay of angiogenesis Expired - Fee Related GB2331763B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9821068A GB2331763B (en) 1997-10-01 1998-09-29 A Multicellular in vitro assay of angiogenesis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9720987.8A GB9720987D0 (en) 1997-10-01 1997-10-01 A multicellular in vitro assay of angiogenesis
GB9821068A GB2331763B (en) 1997-10-01 1998-09-29 A Multicellular in vitro assay of angiogenesis

Publications (4)

Publication Number Publication Date
GB2331763A9 GB2331763A9 (en)
GB9821068D0 GB9821068D0 (en) 1998-11-18
GB2331763A GB2331763A (en) 1999-06-02
GB2331763B true GB2331763B (en) 2000-03-22

Family

ID=26312360

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9821068A Expired - Fee Related GB2331763B (en) 1997-10-01 1998-09-29 A Multicellular in vitro assay of angiogenesis

Country Status (1)

Country Link
GB (1) GB2331763B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995023968A1 (en) * 1994-03-04 1995-09-08 The Australian National University In vitro angiogenesis assay

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995023968A1 (en) * 1994-03-04 1995-09-08 The Australian National University In vitro angiogenesis assay

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Exp.Cell Research 1994 215(2) pp310-318 *
Histochem. & Cell Biology 1995 104(6) pp459-466 *
J. of Cell Science 1993 105(4) pp1013-1024 *
Lab. Investigation 1994 71(2) pp291-299 *

Also Published As

Publication number Publication date
GB9821068D0 (en) 1998-11-18
GB2331763A (en) 1999-06-02
GB2331763A9 (en)

Similar Documents

Publication Publication Date Title
GB2322192B (en) Assay devices
GB9719044D0 (en) Assay
EP0804727A4 (en) In vitro angiogenesis assay
GB9815224D0 (en) Assay
GB9715522D0 (en) Assays
GB9721240D0 (en) Assay
GB2331763B (en) A Multicellular in vitro assay of angiogenesis
PL338828A1 (en) Pharmacological suspension containing nevirapin hemihydrate
GB9727277D0 (en) Assay
IL134135A0 (en) Electroconductive ceramic material
GB2320908B (en) Rigid coloured article
GB9703717D0 (en) Illuminated article
PL340458A1 (en) Production of therasosine chlorhydride dihydrate
AU1750095A (en) (in vitro) angiogenesis assay
GB9702187D0 (en) Ware forming
GB9703995D0 (en) Endopeptidase assay
TW329805U (en) Insert-assembled type wall material
GB9719809D0 (en) Assay
GB9716453D0 (en) Assay
GB9707040D0 (en) Assay
GB9725231D0 (en) Assay
GB9714874D0 (en) Assay
GB9721868D0 (en) Assay
GB9726747D0 (en) Assay
GB9710681D0 (en) Ceramic materials

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20140929